NEW YORK--Pfizer has agreed to pay annual subscription fees of an undisclosed amount in order to gain access to Gene Logic’s GeneExpress database for predictive toxicology applications.

DALLAS--Cytoclonal Pharmaceutics announced that it has launched a genome library of commercial reagents called Oasis that has the ability to regulate genes being uncovered by the Human Genome Project.

NEWTOWN, Pa.--Kimeragen here and ValiGene of Paris announced that they will merge to create ValiGen, a functional genomics company that will combine the genomics platform under development at ValiGene with ch

MOUNTAIN VIEW, Calif.--Aclara BioSciences announced that Eric Lander has joined its board of directors.

NEW HAVEN, Conn.--CuraGen announced that Randy Thurman, past president and CEO of Rhone-Poulenc Rorer Pharmaceuticals, has joined its board of directors.

SUNNYVALE, Calif.--Amersham Pharmacia Biotech here announced a marketing agreement with Axon Instruments of Foster City, Calif., in which Amersham will include Axon’s GenePix 4000A microarray scanner as part of its

EXTON, Pa.--3-Dimensional Pharmaceuticals and DuPont Pharmaceuticals have formed a collaboration through which 3DP will use its DirectedDi-versity technology to assist DuPont in the discovery of new drugs for specif

SEATTLE--Geospiza announced that its products will support Amersham Pharmacia Biotech’s MegaBace sequencing platform as well as all major chromatogram file formats.

CLEVELAND--Athersys, a genomics company based here, has filed US patent applications covering more than 10,000 novel gene sequences identified using the company’s Random Activation of Gene Expression for Gene Discovery technology.

CAMBRIDGE, Mass.--Spotfire has launched Spotfire Array Explorer 2.0 for gene expression analysis.

MENLO PARK, Calif.--Deltagen announced the signing of a DeltaSelect research agreement with Schering-Plough Research Institute to validate small molecule drug targets.

HUNT VALLEY, Md.--Oxford Molecular Group has launched OMMM 2.0, designed for use by biologists, pharmacologists, and research managers in the drug discovery screening environment.

PRINCETON, NJ--Orchid Biocomputer said it has changed its name to Orchid BioSciences to reflect the company’s current and future direction in the genetic diversity and pharmacogenetics fields.

WOODBRIDGE, Conn.--Bayer said it has begun expanding its research facilities as a direct result of alliances with Millennium Pharmaceuticals and Lion Bioscience, which have given the pharmaceutical company ac

WASHINGTON--The list of genomics companies planning initial public offerings continues to grow, with Paradigm Genetics, Nanogen, and Sangamo Biosciences about to join the fray.

SAN DIEGO--GeneFormatics announced that it has completed a $4 million venture capital financing round led by Burrill’s AgBio Capital Fund with IngleWood Ventures and Moss Forest Venture, among o

PALO ALTO, Calif.--Incyte Pharmaceuticals said it has entered into a definitive purchase agreement for the sale of two million shares of newly issued common stock to selected institutional investors for $422 million.

OAKLAND, Calif.-- DoubleTwist, a startup life sciences application service provider formerly known as the bioinformatics company Pangea Systems, has raised $37 million in a private placement of equity securities.

BERKELEY, Calif.--With 1999 P&Ls in the black and endorsements from such illustrious customers as Celera, Novartis, Monsanto, and the Institute for Genomic Research, Neomorphic Software could be considered a bioinformatics success story. The company s young officers--Cyrus Harmon, Martin Reese, and Gregg Helt--started up the firm three years ago with licensing fees paid by SmithKline Beecham for an early product they developed as graduate students at University of California, Berkeley. They ve since grown to a staff of 27 and turned profitable without ever calling on venture capitalists.

NEW YORK--Around the US this month, teams of protein-structure-modeling experts scrambled to meet a grant proposal deadline, hoping to be awarded millions of dollars for research that they said will have profound implications for genomics-based drug development.

SAN FRANCISCO--With more than 1,500 registrants, the Genome Tri-Conference 2000 to be held here February 26-March 3, will draw at least 25 percent more attendees than it did last year, according to conference organizer Cambridge Healthtech International of Newton, Mass.

LA JOLLA, Calif.--Privately held Digital Gene Technologies said it would use $22 million that it secured in a recent private placement to accelerate deployment of its automated assay technology and to advance its bioinformatics de

SOUTH SAN FRANCISCO, Calif.--Two more genomics companies announced their intentions to jump on the IPO bandwagon last week.

CAMBRIDGE, Mass.--The Object Management Group announced that its board of directors has adopted a CORBA software standard for biological sequence analysis and genomic maps.

MENLO PARK, Calif.--Deltagen announced that it has completed a $22.5 million round of financing that was led by Boston Millennia Partners and included investments by the Sprout Group, Baccharis